1. Bellgard M, Beroud C, Parkinson K, Harris T, Ayme S, Baynam, et al. Dispelling myths about rare disease registry system development. Source Code Biol Med. 2013;8:21. https://doi.org/10.1186/1751-0473-8-21.
2. Boulanger V, Schlemmer M, Rossov S, Seebald A, Gavin P. Establishing patient registries for rare diseases: rationale and challenges. Pharm Med. 2020;34:185–90. https://doi.org/10.1007/s40290-020-00332-1.
3. Gliklich R, Dreyer N, Leavy M, eds. Registries for Evaluating Patient Outcomes: A User’s Guide. Third edition. Two volumes. (Prepared by the Outcome DEcIDE Center [Outcome Sciences, Inc., a Quintiles company] under Contract No. 290 2005 00351 TO7.) AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. http://www.effectivehealthcare.ahrq.gov/registries-guide-3.cfm.
4. Rare Diseases Collection. In: Orphanet report series. 2020. http://www.orpha.net/orphacom/cahiers/docs/GB/Registries.pdf. Accessed 7 Feb 2021.
5. Rare diseases: natural history studies for drug development guidance for industry. https://www.fda.gov/media/122425/download. Accessed 6 Feb 2021.